IL95839A - Quinoline derivatives, process for their preparation and pharmaceutical compositions containing them - Google Patents

Quinoline derivatives, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL95839A
IL95839A IL9583990A IL9583990A IL95839A IL 95839 A IL95839 A IL 95839A IL 9583990 A IL9583990 A IL 9583990A IL 9583990 A IL9583990 A IL 9583990A IL 95839 A IL95839 A IL 95839A
Authority
IL
Israel
Prior art keywords
dihydro
oxo
methyl
compound
chlorophenyl
Prior art date
Application number
IL9583990A
Other languages
English (en)
Other versions
IL95839A0 (en
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of IL95839A0 publication Critical patent/IL95839A0/xx
Publication of IL95839A publication Critical patent/IL95839A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Measurement Of Radiation (AREA)
  • Holo Graphy (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL9583990A 1989-10-06 1990-09-28 Quinoline derivatives, process for their preparation and pharmaceutical compositions containing them IL95839A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26278289 1989-10-06
JP32229089 1989-12-11

Publications (2)

Publication Number Publication Date
IL95839A0 IL95839A0 (en) 1991-06-30
IL95839A true IL95839A (en) 1995-03-15

Family

ID=26545706

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9583990A IL95839A (en) 1989-10-06 1990-09-28 Quinoline derivatives, process for their preparation and pharmaceutical compositions containing them

Country Status (17)

Country Link
US (1) US5223513A (en:Method)
EP (1) EP0421456B1 (en:Method)
KR (1) KR910007883A (en:Method)
CN (1) CN1050715A (en:Method)
AT (1) ATE116301T1 (en:Method)
AU (1) AU629048B2 (en:Method)
CA (1) CA2026890C (en:Method)
DE (1) DE69015541T2 (en:Method)
FI (1) FI904915A7 (en:Method)
HU (1) HUT55364A (en:Method)
IE (1) IE903454A1 (en:Method)
IL (1) IL95839A (en:Method)
NO (1) NO904300L (en:Method)
NZ (1) NZ235582A (en:Method)
PT (1) PT95515A (en:Method)
RU (1) RU2001910C1 (en:Method)
TW (1) TW205037B (en:Method)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03181465A (ja) * 1989-12-11 1991-08-07 Takeda Chem Ind Ltd キノリン誘導体
FI934710A7 (fi) * 1991-04-26 1993-10-25 Pfizer 4-aryyli-3-(heteroaryyliureido)kinoliinijohdannaisia
WO1993015058A1 (en) * 1992-01-23 1993-08-05 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
TW241258B (en:Method) * 1992-04-15 1995-02-21 Takeda Pharm Industry Co Ltd
US6001860A (en) * 1992-05-28 1999-12-14 Pfizer Inc. N-aryl and N-heteroarylurea derivatives as inhibitors of acyl coenzyme A: Cholesterol acyl transferase (ACAT)
NO179904C (no) * 1992-09-04 1997-01-08 Takeda Chemical Industries Ltd Kondenserte heterocykliske forbindelser og deres anvendelse
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
TW263498B (en:Method) * 1993-11-10 1995-11-21 Takeda Pharm Industry Co Ltd
US6133326A (en) 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
US5843957A (en) * 1995-05-19 1998-12-01 Sumitomo Pharmaceuticals Company, Ltd. Naphthyridine derivatives
US5972961A (en) * 1997-08-28 1999-10-26 Bristol-Myers Squibb Company 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
US6452008B2 (en) 1998-02-25 2002-09-17 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for preparing the same
AU2547399A (en) 1998-02-25 1999-09-15 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for producing the same
AU755202B2 (en) * 1998-12-04 2002-12-05 Bristol-Myers Squibb Company 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
UA75345C2 (en) 2000-02-02 2006-04-17 Warner Lambert Co Pharmaceutical composition for topical use intended for treating sebaceous gland disorders and methods of treating acnes using this composition
CA2439663C (en) * 2001-03-02 2012-04-03 Sumika Fine Chemicals Co., Ltd. Process for producing quinoline-3-carboxylic acid compound
CA2445693A1 (en) * 2001-04-30 2002-11-07 Pfizer Products Inc. Compounds useful as intermediates for 4-aminoquinoline derivatives
JP4794445B2 (ja) 2003-09-23 2011-10-19 メルク・シャープ・エンド・ドーム・コーポレイション キノリンカリウムチャネル阻害剤
ES2609773T3 (es) * 2011-11-04 2017-04-24 F. Hoffmann-La Roche Ag Nuevos derivados de arilquinolina

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1216878B (de) * 1963-04-02 1966-05-18 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von coronargefaesserweiternden Derivaten des 7-Hydroxy-2-oxo-1, 2-dihydrochinolins
NO133758C (en:Method) * 1970-04-04 1976-06-23 Takeda Chemical Industries Ltd
JPS555502B1 (en:Method) * 1971-07-31 1980-02-07
US4530931A (en) * 1983-01-03 1985-07-23 Usv Pharmaceutical Corp. 8-Quinoline carbanilates for the inhibition of lipolysis
EP0166354B1 (en) * 1984-06-26 1992-08-05 Merck & Co. Inc. Benzofused lactam compounds and pharmaceutical compositions containing them
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use

Also Published As

Publication number Publication date
IE903454A1 (en) 1991-04-10
HU906360D0 (en) 1991-04-29
NO904300L (no) 1991-04-08
KR910007883A (ko) 1991-05-30
CN1050715A (zh) 1991-04-17
FI904915A0 (fi) 1990-10-05
IL95839A0 (en) 1991-06-30
TW205037B (en:Method) 1993-05-01
EP0421456B1 (en) 1994-12-28
RU2001910C1 (ru) 1993-10-30
JPH03223254A (ja) 1991-10-02
PT95515A (pt) 1991-08-14
ATE116301T1 (de) 1995-01-15
CA2026890C (en) 2001-09-18
AU6370790A (en) 1991-04-11
EP0421456A3 (en) 1991-05-29
DE69015541D1 (de) 1995-02-09
US5223513A (en) 1993-06-29
NZ235582A (en) 1992-03-26
AU629048B2 (en) 1992-09-24
CA2026890A1 (en) 1991-04-07
EP0421456A2 (en) 1991-04-10
NO904300D0 (no) 1990-10-03
DE69015541T2 (de) 1995-06-01
HUT55364A (en) 1991-05-28
FI904915A7 (fi) 1991-04-07

Similar Documents

Publication Publication Date Title
CA2026890C (en) Quinoline derivatives, their production and use
EP0354994B1 (en) Quinoline derivatives, their production and use
US3702849A (en) 4-(isoquinolin-1-yl) piperazine-1-carboxylic acid esters
US5700810A (en) Condensed heterocyclic compounds, their production and use
NO171785B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinazolinderivater
CA2071224C (en) Quinoline derivatives, their production and use
NO794135L (no) Substituerte 4(3h)-kinazolinoner, fremgangsmaate ved fremstilling og anvendelse av disse
US5278186A (en) Chromene derivatives, their production and use
US5264454A (en) Certain 2-oxo-tetrahydro-cycloalkyl-benzopyran-3yl ureas having acyl-CoA-cholesterol acyl transferase inhibitory activity
JPH0710844A (ja) 縮合複素環化合物、その製造法および剤
EP0138491A2 (en) Substituted 2(1H)-quinazolinone-1-alkanoic acids and esters
PL88788B1 (en) Triazolo-isoindole and triazolo-isoquinoline derivatives and their manufacture and uses[gb1477302a]
HINO et al. Synthesis and pharmacological activities of 3-phenyl-2-(1-piperazinyl) quinolines and related compounds
IE51542B1 (en) Therapeutic agents
RU1838301C (ru) Способ получени производного хинолина или его соли
GB2085441A (en) Therapeutic agents
JP3004041B2 (ja) キノリン誘導体、その製法および用途
JPH0753714B2 (ja) Ａｃａｔ阻害剤、キノリン誘導体及びその製造法
KR820000099B1 (ko) 피리도[2, 1-b] 퀴나졸린 유도체의 제조방법
CN101870692A (zh) 一种新型哌嗪基哒嗪类化合物

Legal Events

Date Code Title Description
RH Patent void